# OnCo record paper-cortazar-ctneobc-pcr-pooled-analysis-lancet-2014 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cortazar-ctneobc-pcr-pooled-analysis-lancet-2014/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cortazar-ctneobc-pcr-pooled-analysis-lancet-2014" ;
  schema:name "Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis"@en ;
  schema:description "The US regulator's pooled analysis of 11,955 patients in 12 trials that found complete disappearance of the tumour before surgery predicts survival most strongly in triple-negative disease, but that a trial raising the complete response rate does not reliably improve survival."@en ;
  schema:url <https://onco.cc/key-papers/paper-cortazar-ctneobc-pcr-pooled-analysis-lancet-2014/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(13)62422-8>, <https://pubmed.ncbi.nlm.nih.gov/24529560/> ;
  onco:tag "tnbc-evidence" ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(13)62422-8> ;
  schema:datePublished "2014"^^xsd:gYear ;
  schema:author "Cortazar P, Zhang L, Untch M, et al." ;
  onco:related <https://onco.cc/key-papers/paper-liedtke-neoadjuvant-response-survival-tnbc-jco-2008/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:terms <https://onco.cc/terms/pcr/>, <https://onco.cc/terms/efs/>, <https://onco.cc/terms/os/>, <https://onco.cc/terms/hazard-ratio/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-trial-design/> ;
  onco:journals <https://onco.cc/journals/lancet/> .